ENTRESTO 16 mg/1

ENTRESTO 16 mg/1 is a combination of sacubitril and valsartan, used for managing heart failure. This oral pellet formulation supports cardiovascular health and is manufactured by Novartis Pharmaceuticals Corporation.

ENTRESTO 16 mg/1 is primarily used to treat heart failure, helping to improve heart function and reduce symptoms. This medication works by relaxing blood vessels and reducing the workload on the heart. It is often prescribed for long-term management of heart failure, aiming to enhance overall cardiovascular health.

Common effects of ENTRESTO 16 mg/1 may include dizziness, low blood pressure, and cough. Some users might experience fatigue or kidney problems. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

ENTRESTO 16 mg/1 should be handled with care, especially for individuals with kidney issues or those who are pregnant. It is crucial to follow the prescribed dosage and avoid sudden discontinuation without medical advice. Regular check-ups are recommended to monitor heart and kidney function.

ENTRESTO 16 mg/1 may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), diuretics, and certain heart medications. Alcohol consumption should be moderated, as it can enhance the effects of the medication. Always inform your healthcare provider about all medications you are taking.